semaglutide alcohol reduction Ozempic Can Curb Cravings in Use Disorder, Landmark Trial Finds Study finds semaglutide associated with

How much protein should I eat on a GLP-1

The GLP-1/GIP dual agonist, HRS9531, from Hengrui, reported positive Phase 3 results in weight loss, and is the second (after Innovent) Chinese company to submit marketing authorisation for an obesity asset

LifeMD and Shedrx represent two distinct telehealth models for GLP-1 medication access, each with different clinical oversight structures and pricing strategies

Last, we call upon clinicians, researchers, regulators, and industry stakeholders to address existing gaps in accessibility and explore opportunities for enhancing the use of GLP-1R agonists in both individualized care and broader public health contexts